期刊
ACS APPLIED MATERIALS & INTERFACES
卷 7, 期 34, 页码 18920-18923出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsami.5b06250
关键词
antibody; nanomedicine; drug delivery; toxicity; breast cancer
资金
- Biotechnology and Biological Sciences Research Council [BB/J008656/1]
- Worldwide Cancer Research [12-1054]
- EU FP7-ITN Marie-Curie Network programme RADDEL [290023]
- European Metrology Research Program, Engineering and Physical Sciences Research Council [NEW02-REG3, EP/I014470/1]
- Wellcome Trust Medical Engineering Centre
- Graduate School International Research Award (GSIRA)
- Biotechnology and Biological Sciences Research Council [BB/J008656/1] Funding Source: researchfish
- Engineering and Physical Sciences Research Council [EP/I014470/1] Funding Source: researchfish
- Worldwide Cancer Research [12-1054] Funding Source: researchfish
- BBSRC [BB/J008656/1] Funding Source: UKRI
- EPSRC [EP/I014470/1] Funding Source: UKRI
Polyethylene glycol-functionalized nanographene oxide (PEGylated n-GO) was synthesized from alkyne-modified n-GO, using solvent-free click-mechanochemistry, i.e., copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC). The modified n-GO was subsequently conjugated to a mucin 1 receptor immunoglobulin G antibody (anti-MUC1 IgG) via thiolene coupling reaction. n-GO derivatives were characterized with Fourier-transformed infrared (FT-IR) spectroscopy, thermogravimetric analysis (TGA), Bradford assay, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and atomic force microscopy (AFM). Cell targeting was confirmed in vitro in MDA-MB-231 cells, either expressing or lacking MUC1 receptors, using flow cytometry, confocal laser scanning microscopy (CLSM) and multiphoton (MP) fluorescence microscopy. Biocompatibility was assessed using the modified lactate dehydrongenase (mLDH) assay.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据